title: Validation and the future of stimulation therapy of the primary motor cortex.
abstract: The use of electrical motor cortex stimulation (EMCS) for post-stroke pain was established in Japan and has spread globally. EMCS has been used for the treatment of neuropathic pain, Parkinson's syndrome, and recovery of motor paresis. Since 2000, repetitive transcranial magnetic stimulation (rTMS) has been developed for the treatment of various neurological disorders. rTMS is a non-invasive method with almost no adverse effects. In the USA, rTMS of the left dorsolateral prefrontal cortex was approved for the treatment of major depression in 2008. rTMS of the primary motor cortex (M1) has been studied worldwide for the treatment of neuropathic pain, Parkinson's disease, motor paresis after stroke, and other neurological problems. New methods and devices for rTMS therapy are under development, and rTMS of the M1 is likely to be established as an effective therapy for some neurological disorders. The present review discusses EMCS and rTMS of the M1 concisely.
authors: Department of Neuromodulation and Neurosurgery Office for University-Industry Collaboration, Osaka University, Osaka, Japan. neurosaitoh@mbk.nifty.com
authors: Youichi
authors: Y
authors: Saitoh
mesh_terms: D001927:Brain Diseases / Q000503:physiopathology / Q000628:therapy*; D004599:Electric Stimulation Therapy / Q000379:methods / Q000592:standards* / Q000639:trends*; D005544:Forecasting; D006801:Humans; D007564:Japan; D009044:Motor Cortex / Q000033:anatomy & histology / Q000502:physiology* / Q000601:surgery; D015203:Reproducibility of Results; D050781:Transcranial Magnetic Stimulation / Q000379:methods / Q000592:standards* / Q000639:trends*